Xtant Medical Holdings, Inc. financial data

Symbol
XTNT on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
664 Cruiser Lane, Belgrade, MT
State of incorporation
DE
Fiscal year end
December 31
Former names
Bacterin International Holdings, Inc. (to 8/3/2015), K KITZ INC (to 5/21/2010)
Latest financial report
10-K - Q4 2024 - Mar 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 230 % -11.1%
Quick Ratio 134 % -3.47%
Debt-to-equity 111 % +31%
Return On Equity -36.3 % -2432%
Return On Assets -17.2 % -2142%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 139M shares +6.8%
Common Stock, Shares, Outstanding 139M shares +6.81%
Entity Public Float 30.1M USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 134M shares +12.2%
Weighted Average Number of Shares Outstanding, Diluted 134M shares +5.42%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 117M USD +28.4%
Research and Development Expense 2.39M USD +78.5%
Selling and Marketing Expense 49.2M USD +28%
General and Administrative Expense 28.7M USD +11%
Operating Income (Loss) -12.1M USD -18.9%
Nonoperating Income (Expense) -4.19M USD -146%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.3M USD -1468%
Income Tax Expense (Benefit) 187K USD -96.4%
Net Income (Loss) Attributable to Parent -16.4M USD -2592%
Earnings Per Share, Basic -0.12 USD/shares -1300%
Earnings Per Share, Diluted -0.12 USD/shares -1300%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.2M USD +8.47%
Accounts Receivable, after Allowance for Credit Loss, Current 20.7M USD -0.34%
Inventory, Net 38.6M USD +4.74%
Assets, Current 67.1M USD +3.46%
Property, Plant and Equipment, Net 10.1M USD +16.6%
Operating Lease, Right-of-Use Asset 829K USD -45.6%
Intangible Assets, Net (Excluding Goodwill) 8.36M USD -17.1%
Goodwill 7.3M USD 0%
Other Assets, Noncurrent 103K USD -27%
Assets 93.8M USD +1.32%
Accounts Payable, Current 7.92M USD +12.2%
Accrued Liabilities, Current 7.77M USD -25.4%
Liabilities, Current 28.6M USD +24.3%
Deferred Income Tax Liabilities, Net 42K USD +100%
Operating Lease, Liability, Noncurrent 166K USD -78.1%
Other Liabilities, Noncurrent 38K USD
Liabilities 50.9M USD +23.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -316K USD -1190%
Retained Earnings (Accumulated Deficit) -259M USD -6.77%
Stockholders' Equity Attributable to Parent 43M USD -16.3%
Liabilities and Equity 93.8M USD +1.32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.76M USD -156%
Net Cash Provided by (Used in) Financing Activities 5.18M USD +13.4%
Net Cash Provided by (Used in) Investing Activities -674K USD +96.1%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 139M shares +6.81%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.3M USD +91.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.22M USD +5.03%
Interest Paid, Excluding Capitalized Interest, Operating Activities 740K USD +45.4%
Deferred Tax Assets, Valuation Allowance 28.9M USD +12.3%
Deferred Tax Assets, Gross 29.7M USD +11.6%
Operating Lease, Liability 869K USD -45.3%
Depreciation 2.5M USD +38.9%
Payments to Acquire Property, Plant, and Equipment 773K USD +69.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -16.8M USD -2537%
Lessee, Operating Lease, Liability, to be Paid 922K USD -46.3%
Property, Plant and Equipment, Gross 30M USD +5.63%
Operating Lease, Liability, Current 703K USD -15.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 154K USD -77.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 741K USD -19.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 53K USD -58.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 22K USD -81.5%
Deferred Tax Assets, Operating Loss Carryforwards 19.2M USD +2.87%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5K USD
Additional Paid in Capital 303M USD +2.86%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.7M USD +21.4%
Depreciation, Depletion and Amortization 1.01M USD +113%
Interest Expense 3.2M USD +67.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%